search
Back to results

Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis (CBTSZ)

Primary Purpose

Schizophrenia, Schizoaffective Disorder, Psychotic Disorders

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Integrated Neurocognitive Therapy (INT)
Integrated Psychological Therapy (IPT)
COGPACK
Sponsored by
Psychiatric University Hospital, Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Schizophrenia focused on measuring cognitive behavioural therapy, psychotic disorder, schizophrenia, schizoaffective disorder, psychological intervention

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Participants are competent to give informed consent.
  • Diagnosis of Schizophrenia or Schizoaffective Disorder (ICD-10).
  • Participants are between 18 and 65 years of age.
  • Fulfillment of regular compulsory education.
  • German language proficiency as a native speaker or level B1

Exclusion Criteria:

  • Unwilling or unable to comply with study instructions.
  • Low Intelligence as stated by failure to accomplish regular compulsory education.
  • Currently in another psychotherapeutic treatment, either in individual or group sessions.
  • Current consumption of Alcohol or illicit Drugs.

Sites / Locations

  • Psychiatrische Universitätsklinik Zürich

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Other

Arm Label

INT

IPT

CoC

Arm Description

Integrated Neurocognitive Therapy (INT) is a manualized psychological intervention that consists of 30 sessions administered by a therapist and a co-therapist in an open group of 6-8 patients. Sessions will take place twice a week, and each session should last 90 min.

Integrated Psychological Therapy (IPT) is a manualized psychological intervention that consists of 5 modules which can be completed in a variable number of sessions that will be administered by a therapist and a co-therapist in an open group of 6- 8 patients. Sessions will take place twice a week, and each session should last 60 to 90 min.

COGPACK is a computer-based neuropsychological cognitive training program. It will be administered by a trainer in an open group of 6- 8 patients. Sessions will take place twice a week, and each session will last 45 - 60 minutes.

Outcomes

Primary Outcome Measures

Change from Baseline Symptomatology at 12 Months.
The "Positive and Negative Syndrome Scale" (PANSS) was designed to measure the severity of psychopathology in adult patients with a psychotic disorder, mainly schizophrenia and schizoaffective disorder.

Secondary Outcome Measures

Change from Baseline Symptomatology at 12 Months.
The Mini-ICF (mICF) was developed to classify disorders according to the level of functioning and capacity in an abbreviated version.

Full Information

First Posted
October 2, 2017
Last Updated
September 15, 2021
Sponsor
Psychiatric University Hospital, Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT03316664
Brief Title
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis
Acronym
CBTSZ
Official Title
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
June 1, 2018 (Actual)
Primary Completion Date
July 31, 2021 (Actual)
Study Completion Date
August 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Psychiatric University Hospital, Zurich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This randomised three-arm study aims to evaluate the efficacy and feasibility of a cognitive behavioral therapy (INT-Integrated Neurocognitive Therapy for Schizophrenia Patients) in the treatment of schizophrenia patients in an inpatient setting. The intervention will be compared with an active comparator (IPT- Integrated Psychological Therapy) and a control condition. Overall the study will include 90 patients (30 in each arm). Each patient will receive at least 16 sessions of the respective treatment. Baseline and follow up assessments up to 12 months after the intervention will investigate the stability of treatment.
Detailed Description
Psychotic disorders, and particularly schizophrenia, are severe psychiatric disorders, characterized by psychotic symptoms (mainly hallucinations and delusions), disorganized speech, thought and behavior, and negative symptoms like blunted affect. People who have schizophrenia are chronically impaired. Schizophrenia is one of the first causes of disability worldwide with enormous direct and indirect costs. The introduction of antipsychotics revolutionized the treatment and care of schizophrenia patients; remaining the cornerstone of schizophrenia treatment. Although new antipsychotics were introduced, they share the same mechanism of action (dopamine D2 antagonism). To date, nearly one-third to half of the patients still do not or respond poorly to antipsychotic treatment; furthermore, some core symptoms of the disorder are not fully addressed by this type of medication. Parallel to pharmacological treatments, there has been a steady research in psychological interventions for schizophrenia. Current interventions had a more biologic understanding of the disorder and adopted a diathesis-stress model to explain symptoms and course, incorporating adaptation and adjustment through learned and practiced coping strategies. There are many psychological treatments for schizophrenia, although all are considered roughly equivalent, empirical data shows slight differences in efficacy; in particular, Cognitive Behavioural Therapy (CBT) yields small to medium sized effects in addition to psychopharmacological treatment. There are several available manualized psychological group interventions for patients with a schizophrenic psychosis. One the is the "Integrated Psychological Therapy for Schizophrenia Patients (IPT)", it was developed and introduced into clinical practice almost 30 years ago. It combines neurocognitive and social cognitive interventions with social skills and problem- solving approaches, it has been extensively evaluated by several independent groups, in inpatient and outpatient settings as well, showing an overall improvement in participants. During the last decade, the cognitive section of IPT was further developed, with the "Integrated Neurocognitive Therapy for schizophrenia patients (INT)" was the final result of this process, with the peculiarity that it was designed to fit the needs of outpatients. While IPT focuses predominantly on the domains of speed of processing, attention, reasoning, and problem-solving as well as on emotion and social perception; INT in contrast targets all 11 neuro- and social-cognitive MATRICS-domains. Furthermore, INT uses computerized neurocognitive exercises for restitution. Initial trials seem to confirm INT as a feasible and efficient group therapy approach with the potential to improve functional outcome in schizophrenia outpatients The investigators, plan investigational trial to assess the efficacy and feasibility of INT for patients with schizophrenia in an inpatient setting. Therefore, an 8-week, randomized, controlled, assessor-blind, three-parallel-arm trial is planned with patients diagnosed with a schizophrenic psychosis. Following baseline assessment, patients will be randomly assigned to either IPT, INT or a control intervention. All study interventions, i.e.: the experimental intervention, the psychological control intervention, and the control condition will occur simultaneously twice a week to avoid participants from involuntarily switch groups. Therapists of the psychological experimental and control intervention, as well as trainers involved in the control condition, are not involved in the recruitment, assessment, and assignment of participants of the study. Study interventions will be held in group sessions with 6 to 8 participants each; we plan to conduct five such batches till we reach our sample size of at least 30 participants in each intervention arm. Patients undergoing psychological interventions should have some prerequisites and conditions which make them suitable for the intervention; this, however, is not fully compatible with a random allocation of participants. Through randomization there is the possibility that participants are not able to cope with their assigned treatment; therefore in a pragmatic way patients will be allowed to switch in another treatment arm. Accordingly after two weeks; patients will be reassessed; reallocation will be followed according to predefined criteria for excessive demands or under requirement. Participants which switch groups should complete the 8-week intervention in the second assigned group. The assessment at week two will be considered their baseline, with subsequent measures eight weeks later analog to those who did not switch treatment groups. For the final analysis and to preserve randomization the data from those who did not switch treatment groups will be analyzed: however data from the switching groups will be analyzed separately in an ITT fashion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Schizoaffective Disorder, Psychotic Disorders
Keywords
cognitive behavioural therapy, psychotic disorder, schizophrenia, schizoaffective disorder, psychological intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
An 8-week, randomized, controlled, assessor-blind, three-parallel-arm trial is planned with patients diagnosed with a schizophrenic psychosis.
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
82 (Actual)

8. Arms, Groups, and Interventions

Arm Title
INT
Arm Type
Experimental
Arm Description
Integrated Neurocognitive Therapy (INT) is a manualized psychological intervention that consists of 30 sessions administered by a therapist and a co-therapist in an open group of 6-8 patients. Sessions will take place twice a week, and each session should last 90 min.
Arm Title
IPT
Arm Type
Active Comparator
Arm Description
Integrated Psychological Therapy (IPT) is a manualized psychological intervention that consists of 5 modules which can be completed in a variable number of sessions that will be administered by a therapist and a co-therapist in an open group of 6- 8 patients. Sessions will take place twice a week, and each session should last 60 to 90 min.
Arm Title
CoC
Arm Type
Other
Arm Description
COGPACK is a computer-based neuropsychological cognitive training program. It will be administered by a trainer in an open group of 6- 8 patients. Sessions will take place twice a week, and each session will last 45 - 60 minutes.
Intervention Type
Behavioral
Intervention Name(s)
Integrated Neurocognitive Therapy (INT)
Intervention Description
Information already included in arm/group description.
Intervention Type
Behavioral
Intervention Name(s)
Integrated Psychological Therapy (IPT)
Intervention Description
Information already included in arm/group description.
Intervention Type
Other
Intervention Name(s)
COGPACK
Intervention Description
Information already included in arm/group description.
Primary Outcome Measure Information:
Title
Change from Baseline Symptomatology at 12 Months.
Description
The "Positive and Negative Syndrome Scale" (PANSS) was designed to measure the severity of psychopathology in adult patients with a psychotic disorder, mainly schizophrenia and schizoaffective disorder.
Time Frame
Baseline, 2 Weeks, 10 Weeks, 6 Months, and 12 Months.
Secondary Outcome Measure Information:
Title
Change from Baseline Symptomatology at 12 Months.
Description
The Mini-ICF (mICF) was developed to classify disorders according to the level of functioning and capacity in an abbreviated version.
Time Frame
Baseline, 2 Weeks, 10 Weeks, 6 Months, and 12 Months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participants are competent to give informed consent. Diagnosis of Schizophrenia or Schizoaffective Disorder (ICD-10). Participants are between 18 and 65 years of age. Fulfillment of regular compulsory education. German language proficiency as a native speaker or level B1 Exclusion Criteria: Unwilling or unable to comply with study instructions. Low Intelligence as stated by failure to accomplish regular compulsory education. Currently in another psychotherapeutic treatment, either in individual or group sessions. Current consumption of Alcohol or illicit Drugs.
Facility Information:
Facility Name
Psychiatrische Universitätsklinik Zürich
City
Zürich
ZIP/Postal Code
8032
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32903368
Citation
Redlich Bossy M, Mueller D, Seifritz E, Vetter S, Egger ST. Feasibility and Efficacy of a Psychological Therapy for Patients With a Schizophrenic Psychosis in an Inpatient Setting: Study Protocol of a Randomized Switch Controlled Trial. Front Public Health. 2020 Aug 12;8:391. doi: 10.3389/fpubh.2020.00391. eCollection 2020.
Results Reference
derived

Learn more about this trial

Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis

We'll reach out to this number within 24 hrs